In ER+ mammary cancer cells, the interaction of CRABP2 and Lats1 suppresses the ubiquitination of Lats1 to activate Hippo pathway to inhibit the invasion and metastasis of ER+ mammary cancer. Here, CRABP2 is linked to breast cancer.